In addition, we performed Kaplan-Meier survival analysis for the prognostic significance of NPTX2 expression in ovarian carcinoma patients, and the survival time of patients with high NPTX2 expression was significantly lower in the TCGA dataset than in patients with low expression (Figure 1D). The gene discussed is NPTX2; the disease is ovarian carcinoma.